A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children
ConclusionsPLEX is an overall well-tolerated second-line treatment option for pediatric patients with severe acute CNS demyelinating events with limited response to PS.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Brain | Children | Disability | Gastroenterology | Headache | Hypofibrinogenemia | Migraine | Multiple Sclerosis | Neurology | Pediatrics | Study | Thrombocytopenia | Thrombosis